Close

At AlbaCore, we focus on the long-term. As one of Europe’s leading alternative credit specialists, we invest in private capital solutions, opportunistic and dislocated credit, and structured products. 

Discover more
Close

Specialist in Asia Pacific, Japan, China, India and South East Asia and Global Emerging Market equities.

Discover more
Close

Our philosophy is very simple. We are constantly searching for high quality businesses and when we acquire them, we will work relentlessly with them to create long-term sustainable value through innovation, ESG-led and proactive asset management.

Discover more
Close

formerly Realindex Investments

Leader in active quantitative equities across Australian equities, global equities, emerging markets and global small companies.

Backed by a unique blend of research, portfolio construction and risk management, focused on uncovering original insights and translating them into investment strategies that are active and systematic, aiming to generate alpha.

Discover more
Close

At Stewart Investors, we believe in putting people first. Our investment world-view is of a series of partnerships – with each other, with our clients, with the companies we invest in, the people who buy their goods and services, and with the wider society in which we all live and work.

Discover more

Company engagement helps to improve worker protections

Top Glove is one company identified as part of this engagement as having high exposure to modern slavery risk in light of the COVID-19 pandemic. The company is the world’s largest manufacturer of rubber gloves, specialising in examination, surgical, household and industrial gloves.

It produces over 45 billion gloves per year and has around 25% global market share1. The FSSA team first met management in 2003 and has been a shareholder at various times in the years since.

Top Glove was a clear beneficiary of the surging demand for PPE as the pandemic began to unfold. We had first engaged with this company on modern slavery risks in late 2018 after a number of allegations, reported in the British press, about practices that could constitute modern slavery. The four key issues were: debt bondage; workers exceeding overtime limits; retention of passports; and unsafe factory conditions.

Our conversations with the CFO at the time helped us make our own independent assessment and we were encouraged by notable changes the company was making with regard to its treatment of its workers. These included a mandatory rest day, workers no longer paying recruitment fees and passports being kept safe in workers’ dormitories.

We wrote to Top Glove in June 2020 regarding the heightened risk of modern slavery risk in their supply chain. The company provided answers, but our assessment was that these were fairly limited and that the supplier engagement/labour sourcing policies could have been more robust.

Following this, and ahead of our reengagement, the US Customs and Border Protection (CBP) ordered a Withhold Release Order (WRO) on two of Top Glove’s largest subsidiaries. The WRO targeted recruitment fees (believed to facilitate debt bondage) that had not been remediated to workers hired before January 2019. This is significant as 80% of Top Glove’s workforce were hired between 2015-2019 and hadn’t yet been reimbursed. The Ministry of Manpower in Malaysia investigated Top Glove’s factories (as it had in response to the 2018 allegations) and declared that there were no instances of ‘modern slavery’. However, it was clear to us that recruitment fees must be reimbursed for the WRO to be lifted.

Following the company’s reply to our letter and the CBP action, we spoke with management to hear further details first-hand and encourage better practice. The company disclosed that it had set aside RM50m for remediation and shared a third-party audit with us. We did not view the RM50m as sufficient, given the average fee paid, nor did we find the audit to be comprehensive. While we felt the company wanted to do right by its workers, there was clearly a large discrepancy between Malaysian foreign worker standards and international expectations.

We spoke to management about our experience with the Indian Generic Pharma industry which had faced similar issues in the past, and had notably improved since then. We encouraged Top Glove to have more extensive and unannounced auditing and further remediation.

At this point, we made a decision to sell the last of our shares based on both valuation and ESG concerns.

Nonetheless, we have since followed up with the company to ensure total remediation is carried out. We are pleased to confirm that an independent report has been submitted to the CBP. More importantly, the remediation fees have been revised up to RM136m, which we believe will be sufficient to cover all 11,000 workers. Lastly, the company has committed to working with the independent consultant to regularly assess the welfare of workers. We welcome the positive steps being implemented by the company to take care of its workers. 

 

Discover more chapters from our 'Navigating investment in a post-COVID world' report

Read more chapters online 
Download full report

Subscribe to our future research papers, case studies and ‘Investing beyond the next decade’ podcast series

1. All company information referenced has come from the Company Report unless otherwise stated

 

Important Information

This material has been prepared and issued by First Sentier Investors (Australia) IM Ltd (ABN 89 114 194 311, AFSL 289017) (Author). The Author forms part of First Sentier Investors, a global asset management business. First Sentier Investors is ultimately owned by Mitsubishi UFJ Financial Group, Inc (MUFG), a global financial group. A copy of the Financial Services Guide for the Author is available from First Sentier Investors on its website.

This material contains general information only. It is not intended to provide you with financial product advice and does not take into account your objectives, financial situation or needs. Before making an investment decision you should consider, with a financial advisor, whether this information is appropriate in light of your investment needs, objectives and financial situation. Any opinions expressed in this material are the opinions of the Author only and are subject to change without notice. Such opinions are not a recommendation to hold, purchase or sell a particular financial product and may not include all of the information needed to make an investment decision in relation to such a financial product.

To the extent permitted by law, no liability is accepted by MUFG, the Author nor their affiliates for any loss or damage as a result of any reliance on this material. This material contains, or is based upon, information that the Author believes to be accurate and reliable, however neither the Author, MUFG, nor their respective affiliates offer any warranty that it contains no factual errors. No part of this material may be reproduced or transmitted in any form or by any means without the prior written consent of the Author.